Further alternative splicing events, such as deletion of exon 4 and 5 with prognostic relevance in breast cancer [22] and post-translational modifications, such as glycosylation of uPAR leading to molecular weights between 35 and 60 kDa have been described [21]. The gene discussed is PLAUR; the disease is breast cancer.